DCAT Member Company Announcement Forum
Date/Time: Monday, March 21, 2022 - 9:30 AM to 11:30 AM
Location: InterContinental Barclay - Grand Ballroom
Networking & Coffee for registrants: Doors open at 9:00 AM
Get a front row seat to learn of the key strategic developments impacting the pharmaceutical development and manufacturing value chain. This must-attend event consists of short presentations by senior executives of registered DCAT member companies highlighting recent major news that cover the following:
- Mergers and acquisitions (M&A), including post-M&A integration
- Significant manufacturing expansions, including updated timelines for completion and launch
- Other key corporate strategic developments occurring in 2022 and beyond
Pricing and Registration
Please note: DCAT Week 2022 programs are available to employees of DCAT Member Companies only. Not sure if your company is a DCAT member? Click here or call DCAT at 1-609-208-1888.
- DCAT Member Company Price: Complimentary
Please do not use Internet Explorer when accessing the DCAT Week registration site. Google Chrome, Safari, Microsoft Edge or Firefox are preferred.
Please review our Cancellation and Refund Policy here.
Attending DCAT Week Programs
In adherence of COVID-19 protocols and for the safety of our members, all DCAT Week attendees must wear their registered Member Company Name Badge and complete the vaccine check-in. Program and event attendees will be required to provide proof of identification and vaccination at DCAT programs, events, and lounges, including the 94th DCAT Annual Dinner, and all hosted areas. Due to COVID-19 protocols, we anticipate longer than normal wait times for name badge pickup and encourage everyone to be mindful of event start times. See here for more Health & Safety Protocols at DCAT Week 2022 and here for DCAT Member Name Badge Policy.
All materials provided to registrants (including slides, reports, and presented information) are only for their reference. Registrants may not copy, photograph, or redistribute any materials, and they are responsible for any claim for violations of copyright or other intellectual property rights.